ArticleInternational microbiology : the official journal of the Spanish Society for Microbiology2026
In vitro bioactivities and molecular docking analysis of methanolic extract from Phoenix dactylifera L. (cv. Ghars) seeds.
Article in International microbiology : the official journal of the Spanish Society for Microbiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Date palm seeds are an underutilized agro-industrial by-product with potential bioactive value. In this study, the methanolic extract (ME) of Phoenix dactylifera L. (cv. Ghars) seeds was evaluated for its phytochemical composition and selected in vitro biological activities, supported by molecular docking analysis. Total phenolic, flavonoid, and condensed tannin contents were determined, and major phenolic compounds were identified by HPLC. Antioxidant activity was assessed using the ferric reducing antioxidant power (FRAP) assay, antidiabetic activity was evaluated by yeast glucose uptake and α-amylase inhibition assays, antimicrobial activity was screened using agar diffusion, and antibiofilm activity was examined using a crystal violet microtiter plate method. The extract showed moderate antioxidant activity, with an IC50 value of 323.21 µg/mL in the FRAP assay, compared with 4.57 µg/mL for ascorbic acid. α-Amylase inhibition was observed in vitro with an IC50 of 0.23 µg /mL, whereas yeast glucose uptake was only slightly enhanced (16.29% at 20 µg/mL). Antimicrobial screening revealed inhibition zones up to 16 mm against Escherichia coli at 120 µg/mL. Antibiofilm assays demonstrated concentration-dependent inhibition, reaching 90% for Staphylococcus aureus and 77–83% for other tested strains at 1,2 µg/mL. HPLC analysis identified caffeic acid (34.92 µg/mg), rutin (1.58 µg/mg), and catechin (1.04 µg/mg) as major constituents. Molecular docking suggested that rutin and catechin may interact favorably with selected biological targets; however, these results remain predictive. Overall, the findings indicate measurable but moderate in vitro bioactivities, supporting further investigation using standardized assays and in vivo models.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.